A meta-analysis of the performance of the PimaTM CD4 for point of care testing

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Scott, Lesley E ^a   Campbell, Jennifer ^b   Westerman, Larry ^c   Kestens, Luc ^d,e   Vojnov, Lara ^b   Kohastsu, Luciana ^c   Nkengasong, John ^c   Peter, Trevor ^b   Stevens, Wendy ^a,f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b CLINTON HEALTH ACCESS INITIATIVE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

CD4 misclassification; Meta analysis; Pima CD4; Point of care testing

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ANALYZER; ARTICLE; CARIBBEAN; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC TEST ACCURACY STUDY; EUROPE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; POINT OF CARE TESTING; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; UNITED STATES; ADULT; BLOOD; DEVICES; HIV INFECTIONS; MIDDLE AGED;

ADULT; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; MIDDLE AGED; POINT-OF-CARE TESTING; SENSITIVITY AND SPECIFICITY;

EID: 84937790207     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0396-2     Document Type: Article

References (36)

1. UN AIDS. The Gap Report 2014. 2014. http://www.unaids.org/en/resources/campaigns/2014/2014gapreport/gapreport . Accessed November 2014.
2. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 2013. 2013. http://www.who.int/hiv/pub/guidelines/arv2013/en/ .
3. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ. 2010;88:675-80.
4. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
5. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr. 2011;58:e54-9.
6. Stevens WS, Ford N. Time to reduce CD4+ monitoring for the management of antiretroviral therapy in HIV-infected individuals. S Afr Med J. 2014;104:559-60.
7. UNITAID. HIV/AIDS diagnostics technology landscape. 4th ed. 2014. http://www.unitaid.eu/images/marketdynamics/publications/UNITAID-HIV_Diagnostic_Landscape-4th_edition.pdf .
8. World Health Organisation. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision. 2010. http://www.who.int/hiv/pub/arv/adult2010/en/ .
9. World Health Organisation. HIV Programme: Achieving our Goals 2014. http://apps.who.int/iris/bitstream/10665/112666/1/9789241507110_eng.pdf . UNAIDS. Treatment 2015, http://www.unaids.org/sites/default/files/media_asset/JC2484_treatment-2015_en_1.pdf
10. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378:1572-9.
11. Jani IV, Peter TF. How point-of-care testing could drive innovation in global health. N Engl J Med. 2013;368:2319-24.
12. Stevens W, Gelman R, Glencross DK, Scott LE, Crowe SM, Spira T. Evaluating new CD4 enumeration technologies for resource-constrained countries. Nat Rev Microbiol. 2008;6:S29-38.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
14. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003;326:41-4.
15. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, Hatzold K, et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr. 2010;55:1-7.
16. Mnyani CN, McIntyre JA, Myer L. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2012;60:260-4.
17. McBride GB. A proposal for strength of agreement criteria for Lin's Concordance correlation coefficient. Hamilton, New Zealand: NIWA client report HAM2005-062 Report for Ministry of Health; 2005.
18. Mwau M, Adungo F, Kadima S, Njagi E, Kirwaye C, Abubakr NS, et al. Evaluation of PIMA(R) point of care technology for CD4 T cell enumeration in Kenya. PLoS One. 2013;8:e67612.
19. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry. 2002;50:69-77.
20. Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014;17:18809.
21. Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014;11:e1001725.
22. Larson B, Schnippel K, Ndibongo B, Long L, Fox MP, Rosen S. How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa. PLoS One. 2012;7:e35444.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
24. Scott LE, Galpin JS, Glencross DK. Multiple method comparison: statistical model using percentage similarity. Cytometry B Clin Cytom. 2003;54:46-53.
25. Pollock MA, Jefferson SG, Kane JW, Lomax K, MacKinnon G, Winnard CB. Method comparison-a different approach. Ann Clin Biochem. 1992;29:556-60.
26. Denny TN, Gelman R, Bergeron M, Landay A, Lam L, Louzao R, et al. A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study. Cytometry B Clin Cytom. 2008;74:S52-64.
27. Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J Acquir Immune Defic Syndr. 2011;58:141-7.
28. Jani IV, Sitoe NE, Chongo PL, Alfai ER, Quevedo JI, Tobaiwa O, et al. Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS. 2011;25:807-12.
29. Manabe YC, Wang Y, Elbireer A, Auerbach B, Castelnuovo B. Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy. PLoS One. 2012;7:e34319.
30. Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, Camara M, et al. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4. J Acquir Immune Defic Syndr. 2011;58:e103-11.
31. Glencross DK, Coetzee LM, Faal M, Masango M, Stevens WS, Venter WF, et al. Performance evaluation of the Pima point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc. 2012;15:3.
32. Gous N, Scott L, Potgieter J, Ntabeni L, Enslin S, Newman R, et al. Feasibility of performing multiple point of care testing for HIV anti-retroviral treatment initiation and monitoring from multiple or single fingersticks. PLoS One. 2013;8:e85265.
33. Myer L, Daskilewicz K, McIntyre J, Bekker LG. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women. J Int AIDS Soc. 2013;16:18649.
34. Wade D, Daneau G, Aboud S, Vercauteren GH, Urassa WS, Kestens L. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients. J Acquir Immune Defic Syndr. 2014;66:e98-107.
35. Takkouche B, Cadarso-Suarez C, Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol. 1999;150:206-15.
36. Lin LK. A note on the concordance correlation coefficient. Biometrics. 2000;56:324-5.